Sign in

Stoke Therapeutics, Inc.

Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17
Total revenue 0.18 0.04 0.01 0.01 0.00 0.00 0.00 0.00 0.00
Cost of revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Gross profit 0.18 0.04 0.01 0.01 0.00 0.00 0.00 0.00 0.00
Total operating expenses + 0.21 0.14 0.12 0.12 0.09 0.05 0.04 0.01 0.01
Operating income -0.02 -0.10 -0.11 -0.10 -0.09 -0.05 -0.04 -0.01 -0.01
Non-operating income (net) 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax -0.01 -0.09 -0.10 -0.10 -0.09 -0.05 -0.03 -0.01 -0.01
Income tax expense -0.09 0.00 -0.01 0.00 0.00 0.00 0.00 0.00
Net income -0.01 -0.09 -0.10 -0.09 -0.08 -0.05 -0.03 -0.01 -0.01
Show Quarterly Income Statement
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18
Total revenue 0.01 0.00 0.01 0.01 0.16 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cost of revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Gross profit 0.01 0.00 0.01 0.01 0.16 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total operating expenses + 0.06 0.06 0.05 0.04 0.05 0.04 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00
Operating income -0.05 -0.06 -0.04 -0.03 0.11 -0.01 -0.03 -0.03 -0.03 -0.03 -0.03 -0.03 -0.02 -0.03 -0.03 -0.03 -0.02 -0.02 -0.02 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 0.00 0.00 0.00 0.00
Non-operating income (net) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax -0.05 -0.06 -0.04 -0.02 0.11 -0.01 -0.03 -0.03 -0.03 -0.03 -0.02 -0.03 -0.02 -0.03 -0.03 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 0.00 0.00 0.00 0.00
Income tax expense 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net income -0.05 -0.06 -0.04 -0.02 0.11 -0.01 -0.03 -0.03 -0.03 -0.03 -0.02 -0.03 -0.02 -0.03 -0.03 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 0.00 0.00 0.00 0.00
4 days ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17
Total cash and short-term investments + 0.28 0.22 0.20 0.23 0.22 0.29 0.22 0.11 0.00
Accounts receivable, net 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventories 0.01 -0.07 0.00 0.00
Other current assets 0.01 0.02 0.01 0.01 0.01 0.01 0.00 0.00 0.00
Total current assets 0.31 0.23 0.22 0.24 0.23 0.29 0.23 0.11 0.00
Total non-current assets + 0.11 0.04 0.01 0.01 0.01 0.00 0.00 0.00 0.00
Total assets 0.42 0.27 0.23 0.26 0.24 0.30 0.23 0.11 0.00
Total current liabilities + 0.06 0.04 0.03 0.03 0.02 0.01 0.00 0.00 0.00
Total non-current liabilities + 0.01 0.00 0.04 0.04 0.00 0.00 0.00 0.00 0.00
Total liabilities 0.07 0.04 0.07 0.07 0.02 0.01 0.00 0.00 0.00
Total stockholders' equity + 0.35 0.23 0.16 0.18 0.22 0.29 0.22 0.11 0.00
Common shares outstanding 59 54 44 39 37 33 18 24 24
Show Quarterly Balance Sheet
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18
Total cash and short-term investments + 0.34 0.28 0.25 0.25 0.36 0.22 0.24 0.28 0.18 0.20 0.21 0.23 0.25 0.23 0.25 0.28 0.29 0.22 0.24 0.25 0.27 0.29 0.19 0.20 0.21 0.22 0.23 0.24 0.10 0.11 0.00 0.00 0.00
Accounts receivable, net 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventories 0.00 0.01 0.01 0.01 0.01 0.00 0.00 0.00
Other current assets 0.02 0.01 0.01 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.02 0.01 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00
Total current assets 0.37 0.31 0.27 0.27 0.38 0.23 0.25 0.30 0.19 0.22 0.23 0.25 0.27 0.24 0.26 0.29 0.31 0.23 0.24 0.26 0.28 0.29 0.20 0.21 0.22 0.23 0.24 0.24 0.10 0.11 0.00
Total non-current assets + 0.08 0.11 0.09 0.11 0.03 0.04 0.04 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Total assets 0.44 0.42 0.36 0.38 0.41 0.27 0.29 0.31 0.21 0.23 0.24 0.26 0.28 0.26 0.28 0.30 0.32 0.24 0.25 0.26 0.28 0.30 0.20 0.21 0.22 0.23 0.24 0.25 0.10 0.11 0.00
Total current liabilities + 0.04 0.06 0.04 0.04 0.04 0.04 0.05 0.04 0.04 0.03 0.03 0.02 0.03 0.03 0.03 0.03 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Total non-current liabilities + 0.01 0.01 0.01 0.01 0.01 0.00 0.01 0.02 0.03 0.04 0.04 0.04 0.04 0.04 0.04 0.05 0.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total liabilities 0.05 0.07 0.05 0.05 0.06 0.04 0.06 0.07 0.06 0.07 0.07 0.07 0.07 0.07 0.07 0.08 0.08 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.01 0.00 0.00 0.00 0.00
Total stockholders' equity + 0.39 0.35 0.31 0.33 0.35 0.23 0.23 0.24 0.14 0.16 0.17 0.19 0.21 0.18 0.20 0.22 0.24 0.22 0.24 0.26 0.27 0.29 0.19 0.20 0.21 0.22 0.23 0.24 0.10 0.11 0.00
Common shares outstanding 63 58 59 58 59 57 56 56 46 45 44 44 43 39 39 39 37 37 37 37 37 35 33 33 33 25 33 31 30 24 24 24 24
4 days ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17
Operating cash flow + 0.05 -0.09 -0.08 -0.03 -0.07 -0.04 -0.03 -0.01 -0.01
Cash flow from investing + -0.19 -0.11 0.11 -0.05 -0.08 0.00 0.00 0.00 0.00
Cash flow from financing + 0.10 0.13 0.05 0.05 0.00 0.11 0.15 0.12 0.01
Change in cash -0.04 -0.06 0.08 -0.03 -0.14 0.06 0.12 0.10 0.00
Show Quarterly Cash Flow
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18
Operating cash flow + -0.06 -0.03 -0.03 -0.03 0.13 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 0.03 -0.02 -0.01 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 0.00 0.00 0.00 0.00
Cash flow from investing + 0.05 -0.06 0.01 -0.15 0.01 0.00 -0.03 -0.09 0.01 0.01 0.01 0.02 0.05 0.02 0.07 0.00 -0.14 0.01 -0.01 -0.08 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash flow from financing + 0.08 0.09 0.00 0.00 0.00 0.00 0.01 0.12 0.00 0.01 0.00 0.00 0.05 0.00 0.00 0.00 0.04 0.00 0.00 0.00 0.00 0.11 0.00 0.00 0.00 0.00 0.00 0.15 0.00 0.09 0.01 0.00 0.01
Change in cash 0.07 0.00 -0.02 -0.17 0.15 -0.02 -0.04 0.01 -0.01 0.00 0.00 0.00 0.08 0.00 0.05 -0.02 -0.06 0.00 -0.02 -0.10 -0.02 0.10 -0.01 -0.01 -0.01 -0.01 -0.01 0.14 -0.01 0.09 0.01 0.00 0.01
4 days ago

Stoke Therapeutics, Inc. (STOK) - Total Current Liabilities

1Y 2Y 5Y Max
9 days ago

Stoke Therapeutics, Inc. (STOK) - Total Liabilities

1Y 2Y 5Y Max
9 days ago

Stoke Therapeutics, Inc. (STOK) - Other Current Assets

1Y 2Y 5Y Max
9 days ago

Stoke Therapeutics, Inc. (STOK) - Short Term Investments

1Y 2Y 5Y Max
9 days ago

Stoke Therapeutics, Inc. (STOK) - Long Term Investments

1Y 2Y 5Y Max
9 days ago

Stoke Therapeutics, Inc. (STOK) - Total Non Current Assets

1Y 2Y 5Y Max
9 days ago

Stoke Therapeutics, Inc. (STOK) - Current Net Receivables

1Y 2Y 5Y Max
9 days ago

Stoke Therapeutics, Inc. (STOK) - Cash And Short Term Investments

1Y 2Y 5Y Max
9 days ago

Stoke Therapeutics, Inc. (STOK) - Cash And Cash Equivalents At Carrying Value

1Y 2Y 5Y Max
9 days ago

Stoke Therapeutics, Inc. (STOK) - Total Current Assets

1Y 2Y 5Y Max
9 days ago